Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment (NCT07416799)
🩺 Plain-English Summary (8th-Grade Level)
This is a single-arm feasibility study employing a pre-post design with a 12-week intervention period. The study utilizes a telehealth-assisted home-based resistance exercise program, with a structured progression from supervised to unsupervised sessions over 12 weeks.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (15 items).
Location: University of Texas Medical Branch, Galveston — Galveston, Texas
Age range: 55 Years to 80 Years
🧪 Interventions in This Study
- Progressive Exercise Program (12 Weeks) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Diagnosis of movement disorders such as multiple sclerosis, parkinson's disease
- Diagnosis of Alzheimer's disease,
- Current diagnosis of severe depression, major psychiatric conditions such as bipolar disorder, psychosis, schizophrenia, or alcoholism that could affect the ability to understand and/or cooperate fully with the protocol.
- Significant cerebral vascular disease
- Concomitant medications with significant cholinergic or anticholinergic effects or adverse effects on cognition, including antipsychotics, tricyclic antidepressants, anticonvulsants, sedative/hypnotics, anxiolytics, glucocorticoids (chronic or frequent intermittent),
- Visual/hearing impairment that would significantly impact the ability to participate in psychometric testing.
- Significant medical illness or organ failure, including hepatic or renal failure, unstable cardiac disease,
- Untreated B12 deficiency or hypothyroidism (stable treatment for at least 3 months is allowable).
- Uncontrolled hypertension: over 160 mmHg systolic or 100 mmHg diastolic (stable treatment is allowable).
- Stage 5 renal impairment (GFR less than 15 or dialysis).
- Participation in another clinical trial.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- University of Texas Medical Branch, Galveston — Galveston, Texas
📞 Contact the Study Coordinator
Phone: (409) 772-1011
Email: lidurgen@utmb.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type2diabetes
- NAD Augmentation in Diabetes Kidney Disease — Boston, Massachusetts
- The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction — Rochester, Minnesota
- Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers — Ann Arbor, Michigan
- The CARING Study: Creating and Restoring Health Through Nutrition Guidance — Washington D.C., District of Columbia
- Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure — Baltimore, Maryland
Explore by condition: All Type2diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.